克洛丹
胰腺导管腺癌
腺癌
医学
内科学
肿瘤科
切除术
癌症研究
免疫组织化学
胰腺癌
总体生存率
生存分析
病理
佐剂
异位表达
比例危险模型
胃肠病学
存活率
转移
过度表达
辅助治疗
胰腺疾病
阶段(地层学)
回顾性队列研究
蛋白质表达
作者
Hyebin Cha,Eden Demere Amare,Yun Kyung Jung,Youn-Lee Oh,Woon Yong Jung,Seungyun Jee,Seongsik Bang,Hwangkyu Son,Kihyuk Song,Hosub Park,Jae Kyung Myung,Seung‐Sam Paik,Yeseul Kim,Hyunsung Kim
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2025-09-26
卷期号:45 (10): 4565-4573
标识
DOI:10.21873/anticanres.17802
摘要
High CLDN18.2 expression is associated with favorable clinicopathologic characteristics and improved survival outcomes in PDAC, especially among patients receiving adjuvant chemotherapy, suggesting its potential as a therapeutic and prognostic marker.
科研通智能强力驱动
Strongly Powered by AbleSci AI